GPO

CoagCo LLC Announces Agreement with CHAMPS GPO for its Innovative Nosebleed Device

Retrieved on: 
月曜日, 6月 3, 2024
General Health, Health, Medical Supplies, Medical Devices, Tertiary referral hospital, Trauma, GPO, CHAMPS, Nosebleed, PVA, Council

CoagCo LLC, a Cleveland-based medical device company, announced today that it has entered into an agreement with CHAMPS Group Purchasing (GPO), a group purchasing organization that leverages the purchasing power of more than 20,000 member locations across the U.S. to support supplier businesses and provide savings to its members.

Key Points: 
  • CoagCo LLC, a Cleveland-based medical device company, announced today that it has entered into an agreement with CHAMPS Group Purchasing (GPO), a group purchasing organization that leverages the purchasing power of more than 20,000 member locations across the U.S. to support supplier businesses and provide savings to its members.
  • CHAMPS GPO will include CoagCo’s proprietary nosebleed device, Coag it NP7®, a nasal packing device designed for painless insertion by secondary providers for nosebleeds in a trauma setting, in its portfolio of contracts offered to members.
  • CoagCo LLC was chosen as an Innovation Fund Award winner in 2023, Northeast Ohio’s most active and successful early-stage fund.
  • "We are excited to partner with CHAMPS GPO to offer a simple, safe and effective, nosebleed device for first responders, Urgent Care Centers, Family Health Centers, and Emergency Rooms," said Susan M. Palmer, Chief Commercial Officer at CoagCo LLC.

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

Retrieved on: 
月曜日, 5月 20, 2024
Partnership, Patient, Hernia, Hospital, GPO, Internationalized domain name, Surgeon, Marketing, Swimming, IDN, Growth, System, Oil tanker, Medtech, NCI, Tourism

MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer.

Key Points: 
  • MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer.
  • “Greg has been an instrumental player in the TELA Bio story, supporting our commercial strategy and cultivating each of our key group purchasing organization (GPO) and integrated delivery network (IDN) relationships,” said Antony Koblish, President and CEO of TELA Bio.
  • “I am grateful for the opportunity to head up the commercial organization at TELA Bio at this critical time,” said Greg Firestone.
  • “We are confident that Greg’s leadership will build upon and sustain this success.”
    To learn more about TELA Bio, visit telabio.com

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Retrieved on: 
月曜日, 5月 6, 2024
Shift, Migraine, FDA, Agitation, Research, EMERGE, Webcast, CNS, Prescription, Reboxetine, Privacy, Medicine, BED, Obstructive sleep apnea, Fibromyalgia, Shift work, Deficit spending, Food, Sleep, System, ADHD, SWD, SYMPHONY, NT1, Therapy, Quality of life, Food and Drug Administration, MDD, Narcolepsy Network, Shirin David, Patient, Somnolence, FOCUS, Safety, Depression, CGRP, Binge eating disorder, Medicare, Cataplexy, Central nervous system, Government, DSM-IV codes, Clinical trial, EDS, NDA, NMDA, GPO, Psychiatry, MD, Idiopathic hypersomnia, Smoking, CMAI, Pivotal, Breakthrough therapy, Growth, Pharmaceutical industry

Auvelity net product sales were $53.4 million for the first quarter of 2024, representing 240% year-over-year growth.

Key Points: 
  • Auvelity net product sales were $53.4 million for the first quarter of 2024, representing 240% year-over-year growth.
  • Total cost of revenue was $6.3 million for the first quarter of 2024.
  • Research and development (R&D) expenses were $36.8 million for the first quarter of 2024, compared to $17.8 million for the comparable period in 2023, respectively.
  • Approximately 95,000 prescriptions were written for Auvelity in the first quarter of 2024, representing a 12% sequential increase versus the fourth quarter of 2023.

Premier, Inc. Reports Fiscal-Year 2024 Third-Quarter Results

Retrieved on: 
火曜日, 5月 7, 2024
Practice Management, Data Analytics, General Health, Health, Consulting, Hospitals, Health Technology, Professional Services, Use, Sale, Investment, Nine Months, Care, GPO, Webcast, ASR, Growth, Definition, Three Months, EPS, Adjustment, Continuum, GAAP, Internet access, Bank

Refer to "Premier's Use and Definition of Non-GAAP Measures" below for information on the company's use of non-GAAP measures.

Key Points: 
  • Refer to "Premier's Use and Definition of Non-GAAP Measures" below for information on the company's use of non-GAAP measures.
  • Results of Operations for the Three Months Ended March 31, 2024
    (As compared with the three months ended March 31, 2023)
    GAAP net revenue of $342.6 million increased 6% from $322.2 million in the prior-year period.
  • Refer to "Supply Chain Services" and "Performance Services" sections below for further discussion on the factors that impacted each segment during the quarter.
  • Free cash flow for the nine months ended March 31, 2024 was $48.1 million compared with $199.5 million in the prior-year period.

HealthTrust Performance Group Celebrates 25 Years of Serving Healthcare

Retrieved on: 
月曜日, 4月 29, 2024
Health, Consulting, Pharmaceutical, Surgery, Professional Services, Practice Management, Mental Health, Medical Devices, Managed Care, Hospitals, Health Technology, Nursing, Cardiology, Medical Supplies, Hospital, GPO, System, HCA Healthcare, Conference, Long-term care, Triad Hospitals, Community Health Systems, Caregiver, LifePoint Health

HealthTrust Performance Group , the leading provider-owned and operated national healthcare performance improvement company, is celebrating 25 years of accelerating savings and optimizing total performance for hospitals, health systems and providers across acute and non-acute sites of care.

Key Points: 
  • HealthTrust Performance Group , the leading provider-owned and operated national healthcare performance improvement company, is celebrating 25 years of accelerating savings and optimizing total performance for hospitals, health systems and providers across acute and non-acute sites of care.
  • “We are honored to celebrate 25 years of helping our members achieve their mission of delivering exceptional patient care,” said Ed Jones, President and Chief Executive Officer.
  • “Our operator expertise, aligned scale and innovation set HealthTrust apart in total performance optimization, spend management, and the development of a resilient global healthcare supply chain.”
    Since its inception, HealthTrust has supported nearly 500 health systems totaling more than 112,000 sites of care.
  • HealthTrust will celebrate 25 years of serving healthcare with members and suppliers during the 2024 HealthTrust University Conference, the company’s esteemed annual event that serves as a pivotal platform for bringing together prominent industry leaders, including HealthTrust executives, and distinguished experts from the healthcare and supply chain domains.

Tech Investments Help SMBs Fortify Supply Chains Amid Economic, Workforce, and Security Concerns

Retrieved on: 
水曜日, 4月 24, 2024
Other Manufacturing, Technology, Professional Services, Manufacturing, Small Business, Software, Retail, Data Management, Supply Chain Management, Supply, Investment, Weather, Risk, Quality control, SMB, GPO, AI, Machine learning, Face, Interface (computing), Luigi, Workforce, Software Advice, SCM

Economic pressures, talent shortages, and cybersecurity threats are plaguing global supply chains, particularly at small to midsize businesses (SMBs).

Key Points: 
  • Economic pressures, talent shortages, and cybersecurity threats are plaguing global supply chains, particularly at small to midsize businesses (SMBs).
  • Software Advice’s international Supply Chain Plans Survey of 1,100 supply chain management (SCM) leaders in the U.S., U.K., Germany, France, and Australia reveals key issues currently impacting SMBs and how they’re building supply chain resilience in the face of these challenges.
  • In fact, 53% of SMB supply chain leaders are negotiating supplier/logistics contracts in 2024, while another 28% plan to start.
  • For more recommendations on building SMB supply chain resilience, read the full report here and check out Software Advice’s list of top supply chain management solutions .

Oracle Helps Healthcare Organizations Solve Critical Supply Chain, HR, and Finance Challenges

Retrieved on: 
火曜日, 4月 23, 2024
Cloud, Organization, Group purchasing organization, Risk, GPO, HR, AI, Health care, ERP, Catalog, HCM, Forecasting, Automation, Pressure, Patient, Oracle Cloud HCM, Oracle Fusion Applications, EPM, Health, SCM

NASHVILLE, Tenn., April 23, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle is introducing new capabilities to Oracle Fusion Cloud Applications Suite to help healthcare organizations drive operational efficiency, empower employees, and improve patient outcomes. The new capabilities within Oracle Fusion Cloud Supply Chain and Manufacturing (SCM), Oracle Fusion Cloud Human Capital Management (HCM), and Oracle Fusion Cloud Enterprise Resource Planning (ERP), will enable healthcare organizations to streamline processes, support increased productivity, help reduce costs, foster employee growth, and better serve patient needs.

Key Points: 
  • To drive more efficient procurement processes and help healthcare organizations better manage spend, Oracle is introducing Oracle Healthcare Marketplace , a B2C shopping experience within Oracle Fusion Cloud Procurement .
  • Oracle Healthcare Marketplace provides a progressive search capability that helps healthcare organizations to:
    Maximize on-contract spend: By integrating all available contracts, including Group Purchasing Organization (GPO), and locally, regionally, and nationally negotiated contracts, Oracle Healthcare Marketplace helps healthcare organizations easily access their full portfolio of contracts and supplier sources.
  • Improve product data accuracy: By automatically cleansing product catalog data, Oracle Healthcare Marketplace helps healthcare organizations improve data consistency and accuracy across source systems.
  • Oracle Healthcare Marketplace is the latest addition to Oracle Cloud SCM to help healthcare organizations optimize planning, automate processes, and enhance visibility across the supply chain.

TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2023 Financial Results

Retrieved on: 
月曜日, 4月 1, 2024
Hydrogen, MGH, Health, Hydrogen peroxide, Sale, Restaurant, Ionization, RELX, International, Webcast, Education, Harvard University, Food industry, GPO, Holiday, Global Biorisk Advisory Council, Academic Medical Center (Amsterdam), Police, Meat, Completion, Transport, Decontamination, Medication, AALAS, American Biological Safety Association, Research, Hospital, Food, ISSA, BIT, CES, Disinfectant, Conference, Horsepower, Growth, Assistant, MIT, Executive, School, Infection, DARPA, Environmental Health (journal), Raymond Castellani, Health care

FREDERICK, Md., April 01, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its fourth quarter and year end 2023 results.

Key Points: 
  • FREDERICK, Md., April 01, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced its fourth quarter and year end 2023 results.
  • Financial Results for the year ended December 31, 2023, compared to December 31, 2022
    Total net revenue was $7,355,000 compared to $8,338,000.
  • Financial Results for the three months ended December 31, 2023, compared to December 31, 2022
    Total net revenue was $1,528,000 compared to $2,812,000.
  • TOMI will hold a conference call to discuss Fourth Quarter and year end 2023 results at 4:30 p.m.

Valify Solutions Group Joins White House Challenge to End Hunger and Build Stronger Communities

Retrieved on: 
水曜日, 3月 27, 2024
Nursing, Other Philanthropy, Medical Supplies, Practice Management, Managed Care, General Health, Family, Public Policy, Government, Other Health, Consumer, Food, Beverage, Retail, Children, Hospitals, Fitness & Nutrition, Philanthropy, Health, Fund Raising, White House, Federal Government, Vitamins, Supplements, Supply Chain Management, Baseball field, Challenge, Organization, R4, Hunger, Woman, Health equity, Sysco, School, Meal, GPO, WIC, CDC, Food Programme, Administration, Meals on Wheels, Agriculture

Valify Solutions Group, the first tech-enabled group purchasing organization (GPO) program with best-in-class terms and rates on hundreds of categories of purchased services, has joined the White House Challenge to End Hunger and Build Healthy Communities.

Key Points: 
  • Valify Solutions Group, the first tech-enabled group purchasing organization (GPO) program with best-in-class terms and rates on hundreds of categories of purchased services, has joined the White House Challenge to End Hunger and Build Healthy Communities.
  • In supporting the nationwide effort, Valify Solutions Group has teamed with Homeplate Solutions, a pioneer in AI-enabled food management ecosystems.
  • Together, Valify Solutions Group, Homeplate Solutions, Foodbuy, Sysco and r4 will work to maximize the buying power of federal funds that local Community-Based Nutrition Providers receive to serve their communities.
  • “We are proud to stand with Homeplate Solutions and our supplier-partners in addressing these societal issues,” said Les Popiolek, CEO of Valify Solutions Group.

Community Oncology Empowered: AllyGPO & BioCareSD Partner to Bring Choice and Growth

Retrieved on: 
木曜日, 4月 4, 2024
Partnership, Patient, Cancer, Conference, Growth, Group purchasing organization, GPO, Nursing

AllyOncology, part of AllyGPO, is a technology-driven GPO focused solely on community oncology.

Key Points: 
  • AllyOncology, part of AllyGPO, is a technology-driven GPO focused solely on community oncology.
  • This singular focus, combined with guidance from practice stakeholders and oncology experts, allows AllyGPO to implement strategies that support the viability and growth of community oncology care.
  • "Our growing membership shows oncology practices seek an ally who brings new investment, technology, and a mission to preserve their independence."
  • BioCareSD, known for its personalized service with 40+ years of experience delivering rare, ultra-rare, and orphan disease therapies, has expanded into oncology drugs.